Terumo BCT
Meghan Lynch has a diverse work experience history. Meghan is currently the Co-Founder of LFG | Lynch Financial Group since September 2022. Prior to that, they worked as a Growth Partner at Patrick Lynch Financial in 2021. Meghan also had roles at Terumo Blood and Cell Technologies as the Quality Systems Compliance Lead and Global Quality Manager from 2019 to 2021. Meghan'searlier experience includes various positions at Novartis, such as QA Manager, Records Management; Deviation & Complaint Writer and Lead Investigator; Lead Chemist; and Chemist I, Chemist II, & Chemist III from 2010 to 2019.
Meghan Lynch attended Regis University, although no specific details about the degree obtained or field of study are provided.
Terumo BCT
9 followers
A global leader in blood management, blood safety, therapeutic apheresis, cell therapy and cell collections. Terumo BCT believes in the potential of blood to do even more for patients than it does today.